Anti-CTLA-4 therapy results in higher CD4 +ICOS hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues

Research output: Contribution to journalArticlepeer-review

162 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-CTLA-4 therapy results in higher CD4 +ICOS hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues'. Together they form a unique fingerprint.

Medicine & Life Sciences